Genuit Group plc (the "Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
The Company announces that on 15 August 2023, Paul James, Chief Financial Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over a total of 2,406 shares (comprising 2,245 shares granted under the Award and 161 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 22 June 2020, which vested on 22 June 2023. Mr. James sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.
Mr. James now holds an interest in a total of 72,832 shares.
The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Paul James | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Financial Officer/Director and PDMR | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Genuit Group plc | ||||
| b)
| LEI
| 2138005IF1N2RKJ6KO18 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of £0.001 each in the capital of Genuit Group plc
GB00BKRC5K31
| ||||
| b)
| Nature of the transaction
| Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options under the Deferred Share Bonus Plan ("DSBP") award granted on 22 June 2020.
| ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
| N/A | ||||
| e)
| Date of the transaction
| 16 August 2023 | ||||
| f)
| Place of the transaction
| Outside a Trading Venue | ||||
Enquiries:
Emma Versluys, Group Legal Counsel and Company Secretary
+44 (0) 1138 315 315
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
